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Summary Statistics from the Swedish National Cancer Registry based on all 110,658 cases of invasive breast
cancer during the 31-year period 1958-1988 were analysed. Age-specific incidence rates increased over
successive calendar periods. The average annual increase in the age-standardised incidence rate was 1.3%, with
the greatest percentage changes among the youngest age groups. During the latter half of the study period, the
rates of increase tended to diminish in the youngest age groups and even reversed significantly among women
from 75 years of age. In analyses using age-period-cohort models, the best fit of the cancer incidence data was
found for the full model which simultaneously considered the effects of age, period and cohort. Cohort effects
were found to be more important than period effects, in terms of model fit. These effects emerged as a
seemingly consistent, and in a logarithmic scale, fairly linear increase in the relative risk of breast cancer
incidence with a 3-fold elevation in women born in the 1950's relative to those born in the 1880's
It is concluded that the rising breast cancer incidence in Sweden is explained chiefly by birth cohort effects,
which indicate persistent secular changes in largely unknown risk factors associated with life style. We could
not in the present data see any clear evidence for an adverse effect of contraceptive or replacement sex steroids
on breast cancer incidence.
Breast cancer is the most frequent female cancer in Western
Europe and the US, both in terms of incidence and mortality
(Parkin & Nectoux, 1991; Stjernsward & Koroltchouk, 1988;
Kohlmeier et al., 1990). Its occurrence has been increasing
substantially in various countries worldwide (Parkin & Nec-
toux, 1991; Miller & Bulbrook, 1986), resulting in lifetime
cumulative incidence rates ranging from 3% in Japan to 9%
in the USA (Muir et al., 1987).
In the US and the Nordic countries, age-adjusted breast
cancer incidence has increased by 40-70% during the last
3-4 decades (Muir et al., 1987; Devesa et al., 1987; Glass &
Hoover, 1990; Holford et al., 1991; Hakulinen et al., 1986;
Ewertz & Carstensen, 1988). This has been observed in both
pre- and postmenopausal age groups (Parkin & Nectoux,
1991). However, in some populations the increase has been
concentrated mostly among younger women (Devesa et al.,
1987; Ewertz & Carstensen, 1988; Caygill & Hill, 1991; Ran-
stam et al., 1990; White et al., 1987), while in others (such as
the USA) it has been seen largely in the oldest groups (Glass
& Hoover, 1990). The incidence trends are in several coun-
tries most importantly explained by increases in successive
birth cohorts (Holford et al., 1991; Hakulinen et al., 1986;
Ewertz & Carstensen, 1988). Therefore, factors that change
from one generation to another should be considered as
possible explanations (Kelsey, 1979; Moore et al., 1983).
Of special interest is the fairly recent introduction of com-
bined oral contraceptives (COC's) and hormone replacement
therapy (HRT) in the postmenopausal period. Such exo-
genous hormones have been associated with an increased risk
of breast cancer (UK National Case Control Study Group,
1989; Steinberg et al., 1991). Studies of Swedish women
(Meirik et al., 1986; Bergkvist et al., 1989) reported a 70%
increased risk of pre- and postmenopausal breast cancers
after more than 12 and 9 years of exposure to COC's and
HRT, respectively. As the intake has become widespread in
Sweden since the 1970's - with some 80% of young women
having ever used COC's (Meirik, 1986) and 20% of peri-
menopausal women HRT (Lindgren, 1993) - it was con-
sidered important to look for evidence of an effect on the
incidence. Our aim was to analyse the national breast cancer
statistics in Sweden, 1958-1988, in order to disentangle time
period and birth cohort as determinants of incidence trends.
Materials and methods
The Swedish Cancer Registry
A nation-wide cancer registry was started in Sweden in 1958.
Physicians responsible for the patient care are obliged to
report all cases of a newly diagnosed cancer to the Cancer
Registry of the National Board of Health and Welfare. Also
pathologists and cytologists are required to report every
cancer diagnosis based on surgically removed tissues,
cytology specimens and autopsies. Therefore, in the majority
of cases, the registry has received and filed two reports on the
same patient. Cancer cases reported only from death certifi-
cates have not been included in the registry. Under-reporting
in the registry was estimated in the 1970's to be about 5%,
mainly for patients over age 75 (Mattsson & Wallgren, 1984).
The reporting is now considered to be close to 100% of all
diagnosed cases (The Cancer Registry, 1991).
The present analyses were based on all 110,658 cases of
invasive breast cancer (ICD-7 code 170), reported from all
medical institutions in Sweden during a 31-year period from
1958 through 1988. On the average, 97% of the registered
patients had their diagnoses based on histopathological
examinations. The proportion of cases diagnosed only at
autopsy ranged from 0.2 to 0.6% in any 1 year, with no
consistent trend during this study period.
Statistical methods
The trend-wise development of the breast cancer incidence
based on annual data (Table I) was analysed by models
assuming that the logarithm of the incidence was a function
of time. Models were estimated for the age-groups 20-24,
... 80-84 and 85 + as well as for the age-standardised
incidence (direct age-standardisation to the Swedish popula-
tion in 1970 (The Cancer Registry, 1991)). Both linear and
non-linear models in time were estimated. Linear models,
which allowed differences between subperiods - of interest in
relation to the introduction of COC's and HRT on the
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Table I Breast cancer incidence rates in Sweden, by age and
women (and numbers of cases)
period. Rates per 100,000
Age Periods
(years) 1959-63 1964-68 1969-73 1974-78 1979-83 1984-88
25-29 3.2 2.7 4.4 5.9 4.9 6.4
(35) (32) (67) (93) (70) (88)
30-34 11.8 13.4 15.1 17.7 21.6 18.6
(137) (147) (183) (271) (341) (264)
35-39 33.4 36.5 38.8 42.5 45.9 48.2
(436) (426) (427) (511) (701) (758)
40-44 74.1 75.8 85.5 83.5 86.9 96.6
(988) (986) (997) (915) (1042) (1469)
45-49 114.9 122.1 137.2 149.5 145.0 157.4
(1514) (1615) (1776) (1730) (1578) (1875)
50-54 116.0 127.7 138.6 152.0 158.6 162.5
(1513) (1657) (1810) (1938) (1813) (1749)
55-59 131.3 140.3 151.8 164.0 177.8 184.7
(1555) (1785) (1927) (2093) (2221) (2072)
60-64 164.2 158.1 181.1 193.0 206.6 229.3
(1705) (1798) (2220) (2365) (2550) (2778)
65-69 187.1 196.2 205.7 232.2 236.2 251.9
(1630) (1899) (2196) (2683) (2741) (2956)
70-74 218.1 238.5 244.2 255.3 274.4 294.5
(1508) (1829) (2108) (2456) (2885) (2134)
75-79 231.8 282.9 286.6 308.3 316.6 308.6
(1106) (1541) (1773) (2194) (2563) (2776)
80-84 255.4 305.0 342.8 341.4 357.6 316.7
(681) (952) (1265) (1492) (1847) (1926)
85- 232.2 323.4 367.7 376.7 377.3 337.2
(317) (547) (779) (1028) (1294) (1451)
Swedish market - were also estimated. The basic model with
a linear time-effect implies an assumption of a constant
annual relative change in cancer incidence.
The age-period-cohort analyses were based on grouped
5-yearly data comprising 13 age groups (20-24, ... 80-84
years) and six time periods defined by time of diagnosis
(1959-1963, . . . 1984-1988), which implied 18 overlapping
birth cohorts (1875-84, 1880-89, ... 1960-69). The age-
period-cohort models were estimated using the Breslow
method (Breslow, 1984) which adjusts for overdispersion.
The age-period-cohort modelling is further discussed in a
statistical Appendix.
Results
Age-specific andage-adjusted incidence rates, by year of
diagnosis 1958-1988
Trends in incidence rates over the 31 year long study period
in nine age groups are illustrated in Figure 1. In general, the
rates increase steadily in all age groups, especially in the four
youngest age-groups. However, the rate of increase appears
to slow down slightly in these and the oldest age groups, as
well as in the age-adjusted curve, during the latter part of the
observation period.
Incidence trends were analysed, first by assuming the same
rate of change during the whole period (Table II). The
age-standardised incidence increased annually by 1.3%. A
significant average annual increase was found in all age-
groups, ranging from 0.9 to 3.0%; the most marked rise was
seen in the two youngest age-groups. To test for possible
non-linear trends, also models including a quadratic trend
term were also estimated (Table II). For the three oldest
age-groups, the quadratic trend term was negative and
strongly significant, indicating that the rate of increase
slowed down in recent years. For all age-groups below 60,
except the 40-44 group, this term was negative but statis-
tically insignificant. In the three age-groups 60-74 years, the
parameter of the quadratic term was positive.
To further elucidate the incidence trends over time - and
to reflect an early period when COC's and HRT were pre-
scribed to only few women and a later one with a rapid
introduction of these respective hormonal drugs - separate
estimates were calculated for the two periods 1958-1973 and
1974-1988 (Table III). The age-standardised incidence in-
creased annually on the average by 1.5% and 0.9% in the
two periods respectively, the growth rate being significantly
slower in the latter period. Among the individual age-groups
the results were consistent with those obtained with the
quadratic trend model. Thus, the growth rate ofthe incidence
dropped considerably in the three oldest age-groups, showing
an actual decrease in the rates. The reduction in growth rates
between periods was also large in the two youngest age-
groups, although not statistically significant. If other cut-off
years than 1974 were used for the definition of the sub-
periods, e.g. 1977, similar results were obtained.
Age-period-cohort analyses
Age-period-cohort modelling revealed some overdispersion in
the full model, the deviance being 82.22 on 44 degrees of
freedom (Table IV). On the basis of the standard Poisson
model, the full model was superior to both the age-period
and age-cohort models. The fit of the age-cohort model
(adjusted R2A-value of 0.883), was better than with the age-
period model (R2A = 0.849), while the fit of the full model
was 0.907. Accounting for the extra-Poisson variation
confirmed that the age-cohort model was inferior to the full
model (Table IV). The greater importance of the cohort than
the period effects was also seen when the submodels were
tested against the full model. Addition of cohort to an age-
period model gave a significant P-value of t0.1%, while
addition of period to an age-cohort model gave a P-value
t1%.
Application of the full model for the presentation of age,
period and cohort effects requires a further assumption in
order to obtain unique parameter estimates (Clayton &
Schifflers, 1987). As cohort effects were more important, i.e.
the age plus cohort model produced a better fit than the age
plus period model (Table IV), we imposed the restriction that
the linear period effect was assumed to be zero (Clayton &
Schifflers, 1987). Cohort effects were computed according to
this approach.
Figure 2 shows the relative incidence (log scale) with the
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Figure 1 Age-specific (selected age-groups) and age-standardised incidence rates of breast cancer in Sweden, by years ofdiagnosis,
1958-1988.
Table II Trends in age-specific breast cancer incidence rates in
Sweden 1958-1988
Model including a quadratic
trend term.
Age Annual Sign of the quadratic term
(years) changea % (+ or -), and P-value
25-29 2.97 - 0.95
30-34 2.26 - 0.13
35-39 1.45 - 0.68
40-44 0.93 + 0.41
45-49 1.19 - 0.25
50-54 1.37 - 0.09
55-59 1.49 - 0.48
60-64 1.39 + 0.029
65-69 1.22 + 0.95
70-74 2.33 + 0.60
75-79 1.09 - <0.001
80-84 1.04 - <0.001
85- 1.50 - <0.001
Age-standardisedb 1.27 - 0.040
aLog-linear model; all estimates statistically significant (P <0.05).
bDirectly standardised to the Swedish population in 1970.
(The last two cohorts are not shown due to uncertain
estimates.) Apparently, there is a steady increase with succes-
sively younger birth cohorts. The relative risk was almost
three times as high in the youngest cohort compared with the
oldest. The relationship between incidence rates and birth
cohorts was fairly linear overall (Figure 2), although there
was some deviation from linearity as shown by the signifi-
cantly better fit of the age-cohort model compared with the
age-drift model. There is possibly a tendency towards a faster
growth rate for the cohorts born after 1940, but the evidence
is not very clear, Relative risk estimates of cohort effects
were also obtained from the age-cohort model. The values of
the RR's were almost identical to those from the full model,
as reported above (data not shown).
Discussion
Our analysis of National Cancer Statistics during a 31-year
period revealed overall some distinct and worrysome patterns
of breast cancer incidence. The overall age-adjusted incidence
increased on the average by 1.3% per year during the study
period, with the greatest increase in the youngest age groups.
Table III Trends in age-specific breast cancer incidence rates in
Sweden in two sub-periods
Annual percentage change'
Age 1958-73 1974-88
25-29 1.82 - 0.03
30-34 2.52 0.50
35-39 1.46 1.14
40-44 1.15 1.63
45-49 1.47 0.50
50-54 1.60 0.81
55-59 1.64 1.39
60-64 0.69 1.66
65-69 0.94 0.89
70-74 0.99 1.49
75-79 2.02 - 0.22b
80-84 2.92 - 0.51c
85 + 4.47 - 0.97c
Age-standardised 1.50 0.885d
aLog-linear models. Test of equal growth rates in the two sub-
periods. bp = 0.001. cp <0.0001. dp = 0.041.
Generally, the rate of increase appeared to diminish with
time, 0.9% in the latter half of the period as compared with
1.5% in the earlier half of the period. The slowing of the
incidence increase was the greatest in the two youngest and
three oldest age groups. Analyses by multivariate modelling
revealed that the incidence development was best explained
as a birth cohort effect. The rise in relative risk was seem-
ingly linear on a log scale in successive birth cohorts, show-
ing an almost 3-fold significantly higher incidence when com-
paring women born in the 1950's with those born in the
1880's.
When interpreting the results of the age-period-cohort
modelling it is important to be aware of the basic assumption
that the effects of age, period and cohort on the incidence
rate are multiplicative. Among other things this means that
the relative difference between birth cohorts is assumed to be
the same at all ages. However, typically we only have obser-
vations for a given birth cohort at a limited number of ages.
Thus the later cohorts are only observed at old ages, while
the most recent ones only are observed at young ages. There-
fore, checking the assumption of multiplicative effects is
difficult. Furthermore, if the relative risk difference between
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Figure 2 Relative risk (RR) of incidence of breast cancer in 16 5-year birth cohorts, using women born in 1875- 1884 as reference.
Logarithmic scale. Mid-year of birth cohort interval. Based on full age-period-cohort model, assuming linear period effect being
zero and accounting for extra-Poisson variability.
different cohorts were to change with age, the results of a
cohort modelling might not be reliable.
Bias due to secular changes in cancer registration or diag-
nostic activities is unlikely. The completeness of the registry
was probably somewhat less in the beginning of the study
period, around 95% in the 1950's as compared with close to
100% during the 1980's (The Cancer Registry, 1991; Mattsson
& Wallgren, 1984). Clearly, non-reporting could not explain
the present findings, particularly not the cohort effects.
Increased diagnostic activities, notably mammographic
examinations, may enhance incidence rates (White et al.,
1990). In Sweden, mammography on clinical grounds became
widespread from the mid 1970's (Bjurstam et al., 1978).
Screening (The National Board of Health and Welfare,
Stockholm, Sweden, 1989) was practiced on a routine basis
from the 1970's in only one of 24 counties of Sweden.
Small-scale randomised trials were started in the early 1980's
in Stockholm and Gothenburg whereas a large-scale ran-
domised trial in women 40-70 years old was started in two
counties in 1977-1978, inviting approximately half of all
women. After demonstrating a reduction in mortality for
women 50 years and older in 1985 (Tabar et al., 1985), the
National Board of Health and Welfare recommended in
1985-1986 that all counties should launch screening pro-
grams among women 40 through 70 years old. The first
county started full-scale activities in 1987, and another one in
1988. The impact of mammographic screening during the
present study period is thus likely to be small. The strongest
effects on incidence in our data were related to birth cohorts,
and not to calendar time periods which would be expected
after institution of population-based mammography. Among
women at ages who had an opportunity for mammography,
a significant increase in incidence was found only for the
group 60-64 years, when comparing the recent period with
the earlier one (Table III). Furthermore, the present statistics
did not include in situ breast cancers, which would be more
readily picked up by mammography as compared with
clinical examinations. Improvement in health care during the
Table IV Summary statistics for different age-period-cohort models
Model with adjustment for
Standard Poisson model extra-Poisson variation
Degrees
Model offreedom Deviance F-test RW Deviance F-test
Age 65 1302
Age + drift 64 207.9
Age + period 60 181.7 3.33 0.849 96.43 3.28
Age + cohort 48 112.9 4.11 0.883 59.12 3.78
Age + period + 44 82.22 0.907 44.00
cohort
The deviance is a measure of the goodness-of-fit of a model. A smaller deviance in principle
implies a better fit, but account must be made for the number of degrees of freedom (df), which
is related to the difference between the number of observational units and the number of
estimated parameters in a given model. For a model where the assumption of a Poisson
distribution is true, the deviance should be of the same order as the number of degrees of
freedom. In such a case the difference in deviance between nested models is
chi-square-distributed. The table reveals extra-Poisson variability where the deviance of the full
age-period-cohort model is larger than the number ofdegrees of freedom. In such a case it is not
suitable to use the standard chi-square test. A specific estimation procedure (the Breslow
procedure), described above has been used. To test for significance of effects, F-tests have been
used in this situation. The submodels are tested against the full age-period-cohort model.
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study period might have enhanced the opportunity for breast
cancers to become diagnosed. However, we do not believe
this to be an important explanation, since medical care has
been equally available since the 1960's to all citizens in
Sweden, regardless of socioeconomic status. Furthermore, the
observed trends were best explained by cohort, rather than
period effects. Data on tumour stage, which would help
elucidate the influence of changing diagnostic pathways, are
unfortunately not available in the Swedish Cancer Regis-
try.
Analyses of breast cancer incidence in various countries
have consistently shown a steady increase with time (Muir et
al., 1987; Devesa et al., 1987; Glass & Hoover, 1990; Holford
et al., 1991; Hakulinen et al., 1986; Ewertz & Carstensen,
1988), also for less recent time periods than the present one.
For instance, in the USA, overall increases in age-adjusted
incidence rates have been fairly stable and in the order of
31% (Devesa et al., 1987) to 45% (Glass & Hoover, 1990)
from the 1950-60's up through the early 1980's, whereafter
an accelerated increase took place. In Denmark the increase
was around 60% during a 40-year period, through 1982
(Ewertz & Carstensen, 1988) and in other Nordic countries
about 40% during a 25-year period (Hakulinen et al., 1986).
The age-specific incidence patterns seemed to differ, however,
between the US and the Nordic countries. Whereas statistics
from Portland, Oregon, showed the greatest rise in the
incidence among those 60 + years old and no change among
those 20-44 years old (Glass & Hoover, 1990), data from
Nordic countries, including the present data, indicated the
greatest proportional increase in age-groups below 50
(Ewertz & Carstensen, 1988). Indeed, we found a significant
decrease in recent years among women 75 years and older
(Table III). In most previous studies, marked cohort effects
were noted (Holford et al., 1991; Hakulinen et al., 1986;
Ewertz & Carstensen, 1988), which were judged to be the
most important explanation in studies analysing simul-
taneously the effects of age, period and cohort (Holford et
al., 1991; Ewertz & Carstensen, 1988).
Assuming that these data reflect real changes in the onset
rates of breast cancer, what etiological hypotheses are plausi-
ble? If the increases are mainly associated with birth cohort,
then data in Figure 2 indicate the need to focus on exposures
that have changed in a constant way from one generation to
the next. Secular trends with decreasing age at menarche,
increasing adult height and more frequent intake of alcohol -
established or tentative risk factors of breast cancer - in
women born in the 1940-50's as compared with those in the
early part of the century can explain only little of the
development (Harris et al., 1992).
Epidemiological studies have implicated long-term
exposure to both combined oral contraceptives and hormone
replacement therapy as risk factors for pre- and post-
menopausal breast cancers, respectively (UK National Case
Control Study Group, 1989; Steinberg et al., 1991; Meirik et
al., 1986; Bergkvist et al., 1989). Both these exposures have
become wide-spread in Western societies in the two last
decades and might therefore contribute to an increased rate
of breast cancer (Harris et al., 1992). Thus, in Sweden,
combined oral contraceptive pills were introduced in 1964
and became extensively used in the 1970's, especially by
young women leading to ever usage rates in 1980's of
70-80%, and intake for more than 4 years in some 40% of
all exposed women (Meirik et al., 1986). Statistics on the
number of defined sold daily doses relative to the population
(Figure 3a, National Corporation of Pharmacies, 1991) dem-
onstrate greatly increasing use of COC's during the mid- and
late 1970's, thereafter fluctuating and decreasing slightly. If
the risk of breast cancer is increased 1.5-2-fold after long-
term intake of combined oral contraceptives (Meirik et al.,
1986) and if there is enough latency time to detect the effect,
there ought to have been a noticeable pattern in the increase
related to birth cohorts, i.e. a further increased risk in
women born in the 1950's and later (Figure 2), as suggested
by some investigators (Caygill & Hill, 1991; Ranstam et al.,
1990). Furthermore, we found no significant change in the
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Figure 3 a, Combined oral contraceptives (ethinylestradiol and
mestranol brands). Sales statistics, i.e. number of defined sold
daily doses/1000 women (DDDM/1000) in the whole of Sweden,
during the period 1971-1991 (National Corporation of Phar-
macies, 1991). b, Non-contraceptive replacement oestrogens (es-
tradiol compounds and conjugated oestrogens). DDDM/1000 in
the whole of Sweden, during the period 1972-1990 (National
Corporation of Pharmacies, 1991).
rate of increase of breast cancer incidence, or rather a
decrease, among young women in the recent period as com-
pared with the early period (Table III) in the 1970's.
With regard to hormone replacement therapy, women in a
Swedish cohort exposed for 10 years or more were reported
to have a 70% increased risk of postmenopausal breast
cancer (Bergkvist et al., 1989). Hormone replacement com-
pounds were released on the Swedish market in the late
1960's, but use escalated according to sales statistics from the
1970's (Figure 3b), with present ever usage rates of about
20% (Lindgren, 1993). From a recent survey (unpublished
data) in a cohort of oestrogen treated women in Sweden
(Persson et al., 1983), it was estimated that more than 50%
of the exposed women had an intake exceeding 6 years.
However, our data give no clear evidence of an effect of
exogenous hormone exposure, since we found seemingly
linear trends in relative risk over birth cohorts without fur-
ther increase in women born in the interval 1925-1940.
Moreover, the slowing of the rate of incidence increase in
recent time periods, further contradict a major impact of
exogenous hormone exposure in Swedish women.
The present findings among the Swedish women may be
due partly to changes in other factors, e.g. a somewhat
increased age at menopause (Bengtsson et al., 1981) and a
substantially decreased age at menarche (Ljung et al., 1974)
in the recent birth cohorts as compared with later ones.
However, nulliparity and age at first birth are less likely to be
of importance, since the proportion of 40 years old nulli-
parous women has not changed substantially. Fertility rates
have rather fluctuated substantially, with the lowest propor-
tion ofnulliparous women at the attained age of 20 years for
women born in 1945-1949 (Population Statistics, 1990).
Thus, for the most part, trends in reproductive behaviour
have been limited and/or irregular. These factors are too
weakly associated with breast cancer in the Nordic countries
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(Ewertz et al., 1990), including Sweden (Adami et al., 1990),
to explain more than a minor part of the 3-fold difference in
breast cancer risk among women born some 70 years
apart.
Hypothetically, endocrine events in the adolescence period
related to improved nutrition and growth acceleration at an
early age (Harris et al., 1992; De Ward & Trichopoulos,
1988), as well as intake of larger quantities of alcohol (Long-
necker et al., 1988)-in women of younger birth cohorts, may
also be important. It has also been suggested that intra-
uterine exposures may influence breast cancer risk (Ekbom et
al., 1992). Evidently, temporal trends in such exposures
would produce birth cohort effects in incidence.
In summary, we find a constant increase of breast cancer
risk with birth cohort and reduced rate of increase in recent
time periods. This points to the importance of unidentified
factors that have been successively introducted to - or with-
drawn - from the Swedish population. Our data, however,
give no clear support - at this time of observation - to the
assumption that oral contraceptive pills or hormone replace-
ment increase breast cancer incidence.
Statistical appendix:
To obtain the effects of age, cohort, and period on breast
cancer incidence, models were fitted on the assumption that
the number of cases constituted a variable with a Poisson
distribution. The effects of age, cohort and period were
assumed to be multiplicative, and the parameters of the
models were estimated by means of the maximum likelihood
method using the program package GLIM (Clayton &
Schiffiers, 1987).
In all analyses, the number of observed cases in each of the
age-period observational cells was generally greater than 100.
Basically, it was assumed that the number of cases observed
had a Poisson distribution, but here the distribution can be
approximated by the normal distribution, which was con-
firmed in the actual estimation. The large number of
observed cases in situation such as the present one often
causes overdispersion (Breslow, 1984). This means that the
unexplained variance is larger than that expected under a
Poisson assumption, without any apparent mis-specification
of the model. To overcome these difficulties, we used the
approach suggested by Breslow (Breslow, 1984), to adjust for
the overdispersion. The Breslow method based on weighted
least squares was employed.
The overdispersion made it unsuitable to employ tests
based on the chi-square distribution. In the testing of
different models, F tests were performed on the basis of the
extra-Poisson models, as well as on the deviances of the
standard Poisson models. The results were similar (Table IV).
The method allowing for extra-Poisson variability gave
parameter estimates that were very close to the standard
maximum likelihood estimates of the Poisson model without
adjustment for overdispersion.
As a measure of the fit of different models compared with
the age-model we have used statistics of the following type
(Holford et al., 1991)
G2A+p/dfA+P
R A= I -
G2AIdfA
where G2 denotes the deviance and dfthe number of degrees
of freedom. This measure shows how much of the variability
that is explained by other factors than age. Inclusion of the
degrees of freedom terms makes it possible to compare two
models with a different number of degrees of freedom.
In the analyses of age-period-cohort models, a fundamen-
tal problem is the linear dependence between the linear age,
period and cohort effects. The non-linear effects, on the other
hand, are uniquely defined, but a meaningful interpretation
requires that the linear effects be included. As the full age-
period-cohort model was a significant improvement on the
submodels, the full model should be used for the computa-
tion of effects of different factors. However, this requires
further restrictions in order to obtain unique linear effects.
Such restrictions cannot be avoided, but they all have draw-
backs. Our choice, following Holford (1991) was based on
the fact that cohort effects were stronger than the period
effects. We therefore assumed that the linear period effect
had a zero slope. With this assumption, it was possible to
obtain estimates of all parameters in the model. The results
presented actually implied a slight modification ofthis princi-
ple, as the restriction used was that the first and last period
effects were equal to zero. This produced results that were
very close to those obtained with the zero period slope
assumption, and the computations were easier. The proce-
dure actually used by us in fact the normalisation rule sug-
gested by Clayton and Schiffiers (1987).
This work was supported by grants from the Swedish Cancer
Society.
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